[Biopharmaceutical Company Galmed Pharmaceuticals Announces Plan to Allocate 50% of Cash Reserves to Cryptocurrency] Odaily Planet Daily reports, according to Prnewswire, that Nasdaq-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. has announced the implementation of a digital asset management strategy. The company plans to invest $10 million (approximately 50% of its current cash reserves) in digital assets. Galmed has established a Cryptocurrency Committee responsible for evaluating and overseeing cryptocurrency-related investment activities. The strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies. To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will offer consulting and operational services.